Interferon-α treatment for acute myelitis and intestinal involvement in severe Behçet's disease.
Monastirli
A
A
Department of Dermatology, School of Medicine, University of Patras, Rio-Patras, Greece. almonast@med.upatras.gr
Chroni
E
E
Georgiou
S
S
Ellul
J
J
Pasmatzi
E
E
Papathanasopoulos
P
P
Tsambaos
D
D
D000208:Acute Disease; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001528:Behcet Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008775:Methylprednisolone / Q000008:administration & dosage*; D009187:Myelitis / Q000175:diagnosis / Q000188:drug therapy*; D013281:Stomatitis, Aphthous / Q000188:drug therapy; D016896:Treatment Outcome; D014456:Ulcer / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D016898:Interferon-alpha; D008775:Methylprednisolone